Clinical Research Directory

Inclusion Criteria: 1. Male patients who are at least 18 years old; 2. The physical condition score of the Eastern Cooperative Oncology Group (ECOG) in the United States is 0 to 2 points. 3. Newly diagnosed patients with advanced prostate cancer confirmed by PSMA PET/CT (including metastatic hormone-sensitive prostate cancer or inoperable locally advanced prostate cancer); 4. No previous treatments for prostate cancer have been received; 5. After assessment, there was no obvious insufficiency of vital organs. 6. Sign the written informed consent form for this study, indicating that they fully understand the purpose and process of this study and are willing to participate in it. Exclusion Criteria: 1. A history of any other active malignant tumor within 2 years (excluding well-treated basal cell or squamous cell skin cancer, superficial bladder cancer, or any other carcinoma in situ currently in complete remission); 2. Prostate biopsy pathology shows sarcomatoid cells, intraductal carcinoma, and neuroendocrine cell components; 3. Accompanied by severe comorbidities, immunosuppression, severe mental illness, severe activity limitation and other conditions that prevent compliance with clinical trials; 4. Currently participating in other clinical trials related to this disease; 5. According to the researcher's judgment, there are relevant evaluations that do not align with the best interests of the subjects' participation in the study (such as affecting the subjects' sense of happiness) or may hinder, restrict or interfere with the research protocol; 6. Concurrent infectious diseases that affect the treatment outcome.